Seminars in Oncology Nursing
Volume 25, Issue 2, Supplement 1 , Pages S20-S28 , May 2009

Clinical Approaches to Special Issues Related to Opioid Therapy

  • Perry G. Fine

      Affiliations

    • Corresponding Author InformationAddress correspondence to Perry G. Fine, MD, Pain Research Center, School of Medicine, University of Utah, Suite 200, 615 Arapeen Drive, Salt Lake City, UT. 84108

References 

  1. Opioid risk management. PainEDU.org Web site. Available at: http://www.painedu.org. (accessed Jan 14, 2008).
  2. Gazelle G, Fine PG. Methadone for pain: No. 75. J Palliat Med. 2004;7:303–304
  3. Webster LR. Methadone-related deaths. J Opioid Manage. 2005;1:211–217
  4. Chugh SS, Socoteanu C, Reinier K, et al. A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med. 2008;121:66–71
  5. Bruera E, Sweeney C. Methadone use in cancer patients with pain: a review. J Palliat Med. 2002;5:127–138
  6. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130
  7. Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest. 2005;128:1348–1356
  8. Teichtahl H, Prodromidis A, Miller B, et al. Sleep-disordered breathing in stable methadone programme patients: a pilot study. Addiction. 2001;96:395–403
  9. Webster LR, Choi Y, Desai H, et al. Sleep-disordered breathing and chronic opioid therapy. Pain Med. 2008;9:425–432
  10. Dimsdale JE, Norman D, DeJardin D, et al. The effect of opioids on sleep architecture. J Clin Sleep Med. 2007;3:33–36
  11. Walker JM, Farney RJ, Rhondeau SM, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007;3:455–461
  12. Harris JD. Management of expected and unexpected opioid-related side effects. Clin J Pain. 2008;24(Suppl 10):S8–S13
  13. Pasternak GW. Molecular biology of opioid analgesia. J Pain Symptom Manage. 2005;29(Suppl):S2–S9
  14. Grilo RM, Bertin P, Scotto di Fazano C, et al. Opioid rotation in the treatment of joint pain. A review of 67 cases. Joint Bone Spine. 2002;69:491–494
  15. Quang-Cantagrel ND, Wallace MS, Magnuson SK. Opioid substitution to improve the effectiveness of chronic noncancer pain control: a chart review. Anesth Analg. 2000;90:933–937
  16. Simpson KH. Individual choice of opioids and formulations: strategies to achieve the optimum for the patient. Clin Rheumatol. 2002;21(Suppl 1):S5–S8
  17. Pasternak GW. Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol Sci. 2001;22:67–70
  18. Kadiev E, Patel V, Rad P, et al. Role of pharmacogenetics in variable response to drugs: focus on opioids. Expert Opin Drug Metab Toxicol. 2008;4:77–91
  19. Fine PG, Portenoy RK. A clinical guide to opioid analgesia. New York, NY: Vendome Group, LLC; 2007;
  20. Ripamonti C, Groff L, Brunelli C, et al. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?. J Clin Oncol. 1998;16:3216–3221
  21. Hale ME, Ahdieh H, Ma T, et al. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study. J Pain. 2007;8:175–184
  22. Gimbel JS, Walker D, Ma T, et al. Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehab. 2005;86:2284–2289
  23. Gimbel J, Ahdieh H. The efficacy and safety of oral immediate-release oxymorphone for postsurgical pain. Anesth Analg. 2004;99:1472–1477
  24. Aqua K, Gimbel JS, Singla N, et al. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. Clin Ther. 2007;29:1000–1012
  25. Ahdieh H, Ma T, Babul N, et al. Efficacy of oxymorphone extended release in postsurgical pain: a randomized clinical trial in knee arthroplasty. J Clin Pharmacol. 2004;44:767–776
  26. Sloan P, Slatkin N, Ahdieh H. Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study. Support Care Cancer. 2005;13:57–65
  27. McIlwain H, Ahdieh H. Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study. Am J Ther. 2005;12:106–112
  28. Matsumoto AK, Babul N, Ahdieh H, et al. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Med. 2005;6:357–366
  29. Kivitz A, Ma C, Ahdieh H, et al. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther. 2006;28:352–364
  30. Adams MP, Ahdieh H. Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover study. Pharmacotherapy. 2004;24:468–476
  31. Adams M, Pieniaszek HJ, Gammaitoni AR, et al. Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways. J Clin Pharmacol. 2005;45:337–345
  32. Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain. 1990;41:273–281
  33. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 1999;81:129–134
  34. Mercadante S, Radbruch L, Caraceni A, et al. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer. 2002;94:832–839

 Based on a symposium held at the 2008 Oncology Nursing Society Congress.

PII: S0749-2081(09)00029-1

doi: 10.1016/j.soncn.2009.03.011

Seminars in Oncology Nursing
Volume 25, Issue 2, Supplement 1 , Pages S20-S28 , May 2009

Article Tools

* Image Usage & Resolution